These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
538 related items for PubMed ID: 24090914
1. Novel N-4-piperazinyl-ciprofloxacin-chalcone hybrids: synthesis, physicochemical properties, anticancer and topoisomerase I and II inhibitory activity. Abdel-Aziz M, Park SE, Abuo-Rahma Gel-D, Sayed MA, Kwon Y. Eur J Med Chem; 2013 Nov; 69():427-38. PubMed ID: 24090914 [Abstract] [Full Text] [Related]
4. Synthesis and biological evaluation of benzo[a]phenazine derivatives as a dual inhibitor of topoisomerase I and II. Zhuo ST, Li CY, Hu MH, Chen SB, Yao PF, Huang SL, Ou TM, Tan JH, An LK, Li D, Gu LQ, Huang ZS. Org Biomol Chem; 2013 Jun 28; 11(24):3989-4005. PubMed ID: 23657605 [Abstract] [Full Text] [Related]
5. Design, synthesis and systematic evaluation of cytotoxic 3-heteroarylisoquinolinamines as topoisomerases inhibitors. My Van HT, Woo H, Jeong HM, Khadka DB, Yang SH, Zhao C, Jin Y, Lee ES, Youl Lee K, Kwon Y, Cho WJ. Eur J Med Chem; 2014 Jul 23; 82():181-94. PubMed ID: 24904965 [Abstract] [Full Text] [Related]
6. Synthesis and topoisomerase II inhibitory and cytotoxic activity of oxiranylmethoxy- and thiiranylmethoxy-chalcone derivatives. Na Y, Nam JM. Bioorg Med Chem Lett; 2011 Jan 01; 21(1):211-4. PubMed ID: 21115246 [Abstract] [Full Text] [Related]
7. Synthesis and biological evaluation of 2-phenol-4-chlorophenyl-6-aryl pyridines as topoisomerase II inhibitors and cytotoxic agents. Thapa P, Kadayat TM, Park S, Shin S, Thapa Magar TB, Bist G, Shrestha A, Na Y, Kwon Y, Lee ES. Bioorg Chem; 2016 Jun 01; 66():145-59. PubMed ID: 27174797 [Abstract] [Full Text] [Related]
8. Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of 2-phenyl- or hydroxylated 2-phenyl-4-aryl-5H-indeno[1,2-b]pyridines. Kadayat TM, Song C, Shin S, Magar TB, Bist G, Shrestha A, Thapa P, Na Y, Kwon Y, Lee ES. Bioorg Med Chem; 2015 Jul 01; 23(13):3499-512. PubMed ID: 26022080 [Abstract] [Full Text] [Related]
9. Pyrroloquinolinone-based dual topoisomerase I/II inhibitor. Dalla Via L, Marzaro G, Ferrarese A, Gia O, Chilin A. Eur J Med Chem; 2014 Apr 22; 77():103-9. PubMed ID: 24631729 [Abstract] [Full Text] [Related]
10. Design, synthesis and biological evaluation of novel 7-alkylamino substituted benzo[a]phenazin derivatives as dual topoisomerase I/II inhibitors. Yao BL, Mai YW, Chen SB, Xie HT, Yao PF, Ou TM, Tan JH, Wang HG, Li D, Huang SL, Gu LQ, Huang ZS. Eur J Med Chem; 2015 Mar 06; 92():540-53. PubMed ID: 25599951 [Abstract] [Full Text] [Related]
11. Design, synthesis and mechanistic study of N-4-Piperazinyl Butyryl Thiazolidinedione derivatives of ciprofloxacin with Anticancer Activity via Topoisomerase I/II inhibition. Aziz HA, El-Saghier AM, Badr M, Elsadek BEM, Abuo-Rahma GEA, Shoman ME. Sci Rep; 2024 Oct 15; 14(1):24101. PubMed ID: 39406816 [Abstract] [Full Text] [Related]
12. Synthesis and pharmacological evaluation of novel bisindolylalkanes analogues. Song YL, Dong YF, Yang T, Zhang CC, Su LM, Huang X, Zhang DN, Yang GL, Liu YX. Bioorg Med Chem; 2013 Dec 15; 21(24):7624-7. PubMed ID: 24262885 [Abstract] [Full Text] [Related]
13. Design and Synthesis of Arylnaphthalene Lignan Lactone Derivatives as Potent Topoisomerase Inhibitors. Chen W, Feng Z, Hu D, Meng J. Med Chem; 2021 Dec 15; 17(8):856-865. PubMed ID: 32520691 [Abstract] [Full Text] [Related]
14. Synthesis of 2,4-diaryl chromenopyridines and evaluation of their topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship. Thapa U, Thapa P, Karki R, Yun M, Choi JH, Jahng Y, Lee E, Jeon KH, Na Y, Ha EM, Cho WJ, Kwon Y, Lee ES. Eur J Med Chem; 2011 Aug 15; 46(8):3201-9. PubMed ID: 21601964 [Abstract] [Full Text] [Related]
15. Synthesis of novel benzoxanthone analogues as non-Camptothecin topoisomerase I inhibitors. Cheng P, Zhu L, Guo W, Liu W, Yao J, Dong G, Zhang Y, Zhuang C, Sheng C, Miao Z, Zhang W. J Enzyme Inhib Med Chem; 2012 Jun 15; 27(3):437-42. PubMed ID: 21770860 [Abstract] [Full Text] [Related]
16. Synthesis of carbazole derivatives containing chalcone analogs as non-intercalative topoisomerase II catalytic inhibitors and apoptosis inducers. Li PH, Jiang H, Zhang WJ, Li YL, Zhao MC, Zhou W, Zhang LY, Tang YD, Dong CZ, Huang ZS, Chen HX, Du ZY. Eur J Med Chem; 2018 Feb 10; 145():498-510. PubMed ID: 29335211 [Abstract] [Full Text] [Related]
17. A new series of 2-phenol-4-aryl-6-chlorophenyl pyridine derivatives as dual topoisomerase I/II inhibitors: Synthesis, biological evaluation and 3D-QSAR study. Karki R, Jun KY, Kadayat TM, Shin S, Thapa Magar TB, Bist G, Shrestha A, Na Y, Kwon Y, Lee ES. Eur J Med Chem; 2016 May 04; 113():228-45. PubMed ID: 26945111 [Abstract] [Full Text] [Related]
18. Synthesis, cytotoxicity and topoisomerase II inhibitory activity of lomefloxacin derivatives. Zhou Y, Xu X, Sun Y, Wang H, Sun H, You Q. Bioorg Med Chem Lett; 2013 May 15; 23(10):2974-8. PubMed ID: 23566520 [Abstract] [Full Text] [Related]
19. Design, synthesis and antiproliferative evaluation of fluorenone analogs with DNA topoisomerase I inhibitory properties. Lee CC, Chang DM, Huang KF, Chen CL, Chen TC, Lo Y, Guh JH, Huang HS. Bioorg Med Chem; 2013 Nov 15; 21(22):7125-33. PubMed ID: 24094433 [Abstract] [Full Text] [Related]
20. Synthesis and biological evaluation of N-substituted benzo[c]phenanthrolines and benzo[c]phenanthrolinones as antiproliferative agents. Genès C, Lenglet G, Depauw S, Nhili R, Prado S, David-Cordonnier MH, Michel S, Tillequin F, Porée FH. Eur J Med Chem; 2011 Jun 15; 46(6):2117-31. PubMed ID: 21435753 [Abstract] [Full Text] [Related] Page: [Next] [New Search]